Skip to main content
. Author manuscript; available in PMC: 2016 Aug 18.
Published in final edited form as: Mol Psychiatry. 2013 Mar 5;19(3):334–341. doi: 10.1038/mp.2013.11

Table 1.

Associations between the minor G allele in rs10158645, CSF concentration of KYNA, HVA and a history of psychosis in euthymic BD patients

Data set rs10158645 MAF CSF KYNA (nM)
CSF HVA (nM)
Psychosis
N r P IEa N r P IEb N OR (95% CI) P
II 0.15 76 0.58 3 × 10−8 65 (36–101)c 72 0.54 7 × 10−7 0.71 (0.15–1.8)c   76 4.0 (1.4–12)    0.011
III 0.15 30 0.48d 7 × 10−3
IV 0.18 565 1.5 (1.1–2.0)
6.5 (1.5–28)e
   0.020
0.013e
II+IV 0.17 641 1.6 (1.2–2.2)
7.3 (1.7–32)e
2 × 10−3
8 × 10−3

Abbreviations: BD, bipolar disorder; CI, confidence interval; CSF, cerebrospinal fluid; HVA, homovanillic acid; IE, indirect effect; KYNA, kynurenic acid; MAF, minor allele frequency; OR, odds ratio. All reported P-values are two sided.

a

IE = indirect effect for mediation. Non-parametric bootstrap method, the PROCESS script for SPSS (see http://afhayes.com/spss-sas-and-mplus-macros-and-code.html). Causal variable = allele frequency in rs10158645, mediator = CSF KYNA concentration and outcome variable = CSF HVA concentration. Direct effect = 43 (−0.53 to 86).

b

Causal variable = CSF KYNA concentration, mediator = CSF HVA concentration and outcome variable = psychosis (0/1). Direct effect = 0.15 (−0.61to 0.90).

c

95% Bootstrap CI (percentile bootstrap = 20 000).

d

Spearman’s coefficient.

e

In sample I, only one patient was homozygous for the minor G allele in rs1018645 and the analysis was performed under an additive model. In sample II, 21 patients were homozygous for the minor G allele (18 with psychosis) and additional analyses under a recessive model was performed in sample II and the combined sample (I+II).